Geng Q - Search Results

1

Long-term outcomes of different bortezomib-based regimens in Chinese myeloma patients.

Wang H, Wang L, Lu Y, Chen X, Geng Q, Wang W, Xia Z. Wang H, et al. Among authors: geng q. Onco Targets Ther. 2016 Jan 28;9:587-95. doi: 10.2147/OTT.S97457. eCollection 2016. Onco Targets Ther. 2016. PMID: 26869803 Free PMC article.

2

Consolidation therapy of arsenic trioxide alternated with chemotherapy achieves remarkable efficacy in newly diagnosed acute promyelocytic leukemia.

Liu CC, Wang H, Wang WD, Zhu MY, Geng QR, Lu Y. Liu CC, et al. Onco Targets Ther. 2015 Nov 12;8:3297-303. doi: 10.2147/OTT.S92486. eCollection 2015. Onco Targets Ther. 2015. PMID: 26622182 Free PMC article.

3

Prognostic significance of neuron-specific enolase in patients with diffuse large B-cell lymphoma treated with rituximab-based immunochemotherapy.

Wang L, Liu P, Geng Q, Chen X, Lv Y. Wang L, et al. Among authors: geng q. Leuk Lymphoma. 2011 Sep;52(9):1697-703. doi: 10.3109/10428194.2011.578187. Epub 2011 Aug 4. Leuk Lymphoma. 2011. PMID: 21815777

4

Serum neuron-specific enolase is correlated with clinical outcome of patients with non-germinal center B cell-like subtype of diffuse large B-cell lymphoma treated with rituximab-based immunochemotherapy.

Wang L, Liu P, Chen X, Geng Q, Lu Y. Wang L, et al. Among authors: geng q. Med Oncol. 2012 Sep;29(3):2153-8. doi: 10.1007/s12032-011-0049-z. Epub 2011 Aug 30. Med Oncol. 2012. PMID: 21877195

5

"Sandwich" Chemotherapy (CT) with Radiotherapy (RT) improves outcomes in patients with stage IE/IIE extranodal natural killer (NK)/T-cell Lymphomas.

Zhang J, Zhu MY, Wang L, Wang H, Wang WD, Geng QR, Lu Y. Zhang J, et al. Asian Pac J Cancer Prev. 2013;14(7):4061-6. doi: 10.7314/apjcp.2013.14.7.4061. Asian Pac J Cancer Prev. 2013. PMID: 23991953 Free article.

6

Serum levels of interleukin-9 correlate with negative prognostic factors in extranodal NK/T-cell lymphoma.

Zhang J, Wang WD, Geng QR, Wang L, Chen XQ, Liu CC, Lv Y. Zhang J, et al. PLoS One. 2014 Apr 10;9(4):e94637. doi: 10.1371/journal.pone.0094637. eCollection 2014. PLoS One. 2014. PMID: 24722378 Free PMC article.

7

Increased serum levels of interleukin-15 correlate with negative prognostic factors in extranodal NK/T cell lymphoma.

Wang H, Zhu JY, Liu CC, Zhu MY, Wang JH, Geng QR, Lu Y. Wang H, et al. Med Oncol. 2015 Jan;32(1):370. doi: 10.1007/s12032-014-0370-4. Epub 2014 Nov 27. Med Oncol. 2015. PMID: 25428383

8

Serum levels of soluble programmed death ligand 1 predict treatment response and progression free survival in multiple myeloma.

Wang L, Wang H, Chen H, Wang WD, Chen XQ, Geng QR, Xia ZJ, Lu Y. Wang L, et al. Oncotarget. 2015 Dec 1;6(38):41228-36. doi: 10.18632/oncotarget.5682. Oncotarget. 2015. PMID: 26515600 Free PMC article.

9

High level of interleukin-10 in serum predicts poor prognosis in multiple myeloma.

Wang H, Wang L, Chi PD, Wang WD, Chen XQ, Geng QR, Xia ZJ, Lu Y. Wang H, et al. Br J Cancer. 2016 Feb 16;114(4):463-8. doi: 10.1038/bjc.2016.11. Epub 2016 Feb 4. Br J Cancer. 2016. PMID: 26882069 Free PMC article.

10

A childhood chemotherapy protocol improves overall survival among adults with T-lymphoblastic lymphoma.

Zhu MY, Wang H, Huang CY, Xia ZJ, Chen XQ, Geng QR, Wang WD, Wang L, Lu Y. Zhu MY, et al. Oncotarget. 2016 Jun 21;7(25):38884-38891. doi: 10.18632/oncotarget.9144. Oncotarget. 2016. PMID: 27150061 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

987 results

Search Page

Filters